Novartis MS pill beats older drug in trials, boosts pipeline hopes - Reuters
Novartis MS pill beats older drug in trials, boosts pipeline hopes Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPaXR3MVBBdGtxMGJRSVQ0NHRoOENMQUdlYWpYWndIazBDb2docE50TkRPd25ENkRqckRmVGs4ZUs4dm01R0RKUFU5dnBOdlJHYWxMa2ZSUmE5bksyYTNpRFdGQkVsRkNxSE15c0RIMF85Y0VkMExPaUJfb1hjZ2t6T18tTWpZTUYta2JMSjZDZjZHeWoyODQ2N1lQN3RWQ0lpLXlRNTlQc01qTUxBRjcwVFNDaXRMVWVtNURkUGNVSlk2bnJrd2ZhNTRLTFlZVFRWZEZ0QnNOOHk3UFdF?oc=5" target="_blank">Novartis MS pill beats older drug in trials, boosts pipeline hopes</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Merck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMWegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com
September 21, 2026 at 05:02 AMNanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology - Reuters
Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology Reuters
September 25, 2026 at 02:14 PMRoche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters
Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters
September 22, 2026 at 11:25 AMWegovy maker Novo shares slump as management grilled on pricing, M&A - Reuters
Wegovy maker Novo shares slump as management grilled on pricing, M&A Reuters
September 21, 2026 at 01:21 PM